← Back to Search

Disinfectant

Enhanced Disinfection for Hospital Room Contamination

N/A
Recruiting
Led By Deverick Anderson, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Anticipated patient stay of ≥48 hours
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1, day 2, day 3, day 4
Awards & highlights

Study Summary

This trial tests if using disinfectant more often can reduce germs in the environment better than usual.

Who is the study for?
This trial is for adult patients in the hospital who are on contact precautions for any reason or have a positive culture for certain infections upon room admission. They must have spent at least one night in their room and expect to stay another 48 hours.Check my eligibility
What is being tested?
The study is testing if using Sani24, a disinfectant with persistent activity for 24 hours, can reduce environmental germs more effectively than standard EPA-registered disinfectants used in routine cleaning.See study design
What are the potential side effects?
Since this trial involves environmental disinfection rather than direct patient treatment, side effects are not directly applicable to patients but may include potential respiratory or skin reactions among staff applying the product.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I expect to stay in the hospital for at least 2 days.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1, day 2, day 3, day 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1, day 2, day 3, day 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in total room contamination in study rooms on study day 2
Secondary outcome measures
Change in total room contamination
Frequency of daily disinfection by EVS or unit personnel (control arm) and study personnel (intervention arms)
Proportion of EIP positive environmental cultures
+8 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Standard EPA-registered disinfectantExperimental Treatment1 Intervention
Application of standard EPA-registered disinfectant by study team
Group II: Sani24Experimental Treatment1 Intervention
Application of a 24-hour continuously acting quaternary ammonium salt disinfectant: Sani24 (PDI Healthcare Inc.) by study team
Group III: ControlActive Control1 Intervention
Routine disinfection completed by hospital staff

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,419,151 Total Patients Enrolled
1 Trials studying Disinfection
50 Patients Enrolled for Disinfection
University of North CarolinaOTHER
166 Previous Clinical Trials
1,448,689 Total Patients Enrolled
Deverick Anderson, MDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
29 Total Patients Enrolled

Media Library

Sani24 (Disinfectant) Clinical Trial Eligibility Overview. Trial Name: NCT05739955 — N/A
Disinfection Research Study Groups: Sani24, Standard EPA-registered disinfectant, Control
Disinfection Clinical Trial 2023: Sani24 Highlights & Side Effects. Trial Name: NCT05739955 — N/A
Sani24 (Disinfectant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05739955 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies left in this clinical trial?

"Per information from clinicaltrials.gov, this trial is not currently accepting any participants. This study was initially posted on February 1st 2023 and the latest update happened on February 13th 2023. However, there are still one other trials open for enrollment at present."

Answered by AI
~551 spots leftby Feb 2026